41,93 €
46,59 €
-10% with code: EXTRA
Pharmacy Use and Costs in Employer-Provided Health Plans
Pharmacy Use and Costs in Employer-Provided Health Plans
41,93
46,59 €
  • We will send in 10–14 business days.
As part of an effort to redesign the TRICARE pharmacy benefit to save costs, the Department of Defense is considering moving from a two-tiered to a three-tiered co-payment system, which will increase the co-payment for some classes and brands of drugs. Providers would, theoretically, have an incentive to prescribe less-costly options. To predict how this move would affect costs and pharmacy utilization, the authors use an existing data resource to determine how beneficiaries age 45 to 64 in pri…
  • SAVE -10% with code: EXTRA

Pharmacy Use and Costs in Employer-Provided Health Plans (e-book) (used book) | bookbook.eu

Reviews

Description

As part of an effort to redesign the TRICARE pharmacy benefit to save costs, the Department of Defense is considering moving from a two-tiered to a three-tiered co-payment system, which will increase the co-payment for some classes and brands of drugs. Providers would, theoretically, have an incentive to prescribe less-costly options. To predict how this move would affect costs and pharmacy utilization, the authors use an existing data resource to determine how beneficiaries age 45 to 64 in private-sector health plans responded to similar changes.

EXTRA 10 % discount with code: EXTRA

41,93
46,59 €
We will send in 10–14 business days.

The promotion ends in 21d.05:36:16

The discount code is valid when purchasing from 10 €. Discounts do not stack.

Log in and for this item
you will receive 0,47 Book Euros!?
  • Author: Geoffrey F Joyce
  • Publisher:
  • ISBN-10: 0833035495
  • ISBN-13: 9780833035493
  • Format: 15.2 x 22.9 x 0.6 cm, minkšti viršeliai
  • Language: English English

As part of an effort to redesign the TRICARE pharmacy benefit to save costs, the Department of Defense is considering moving from a two-tiered to a three-tiered co-payment system, which will increase the co-payment for some classes and brands of drugs. Providers would, theoretically, have an incentive to prescribe less-costly options. To predict how this move would affect costs and pharmacy utilization, the authors use an existing data resource to determine how beneficiaries age 45 to 64 in private-sector health plans responded to similar changes.

Reviews

  • No reviews
0 customers have rated this item.
5
0%
4
0%
3
0%
2
0%
1
0%
(will not be displayed)